Clinical trial
A Study of Quarterly Intravenous Bonviva (Ibandronate) in Women With…
NCT00493532 · Hoffmann-La Roche, Industry · No longer available
Key facts
| NCT number | NCT00493532 |
|---|---|
| Title | A Study of Quarterly Intravenous Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis. |
| Official title | An Open Label Study to Evaluate the Effect on Bone Mineral Density, and the Safety, of Quarterly Intravenous Bonviva in Patients With Post-menopausal Osteoporosis. |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | No longer available |
| Study type | Expanded Access |
| Conditions | Postmenopausal Osteoporosis |
| Intervention type | Drug |
| Interventions | ibandronate [Bonviva/Boniva] |
| Start date | Jun 1, 2007 |
| Primary completion | Dec 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Jun 28, 2007 |
| Last update posted | Nov 2, 2016 |
| Countries | Taiwan |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: